OrbiMed’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

OrbiMed’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,906,000	Closed	-$23.4M	–	139
2022 Q4	$23.4M	Buy	1,906,000 +1,591,798	+507%	+$37.9M	0.45%	63
2022 Q3	$10.3K	Buy	+314,202	New	+$8.88M	0.19%	84

OrbiMed's CINC Position: Q1 2023 in Review

OrbiMed sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 1,906,000 shares — an estimated $23.4M sold.

OrbiMed first reported a position in CINC in Q3 2022 and held it in 2 quarters. The position peaked at $23.4M in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

OrbiMed reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
OrbiMed sold 1,906,000 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $23.4M.
OrbiMed first reported a position in CinCor Pharma, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
OrbiMed's CinCor Pharma, Inc. Common Stock position peaked at $23.4M in Q4 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on OrbiMed's 13F filing for Q1 2023, filed 15 May 2023.